|
|
||||||||
J Thorac Cardiovasc Surg 2001;121:0336-0343
© 2001 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
From the Brain Research Laboratory,a Joseph Stokes Research Institute, Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia, the Department of Anesthesiology and Critical Care Medicine and Pediatrics,b and the Department of Pathology,c University of Pennsylvania School of Medicine, Philadelphia, Pa.
Received for publication June 15, 2000. Revisions requested July 22, 2000; revisions received Sept 28, 2000. Accepted for publication Oct 16, 2000. Address for reprints: Margaret Priestley, MD, Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104 (E-mail: Priestley{at}email.chop.edu).
Objective: Deep hypothermic circulatory arrest for neonatal heart surgery poses the risk of brain damage. Several studies suggest that pH-stat management during cardiopulmonary bypass improves neurologic outcome compared with alpha-stat management. This study compared neurologic outcome in a survival piglet model of deep hypothermic circulatory arrest between alpha-stat and pH-stat cardiopulmonary bypass.
Methods: Piglets were randomly assigned to alpha-stat (n = 7) or pH-stat (n = 7) cardiopulmonary bypass, cooled to 19°C brain temperature, and subjected to 90 minutes of deep hypothermic circulatory arrest. After bypass rewarming/reperfusion, they survived 2 days. Neurologic outcome was assessed by neurologic performance (0-95, 0 = no deficit and 95 = brain death) and functional disability scores, as well as histopathology. Arterial pressure, blood gas, glucose, and brain temperature were recorded before, during, and after bypass.
Results: All physiologic data during cardiopulmonary bypass were similar between groups (pH-stat vs alpha-stat) except arterial pH (7.06 ± 0.03 vs 7.43 ± 0.09, P < .001) and arterial PCO2 (98 ± 8 vs 36 ± 8 mm Hg, P < .001). No differences existed in duration of cardiopulmonary bypass or time to extubation. Performance was better in pH-stat versus alpha-stat management at 24 hours (2 ± 3 vs 29 ± 17, P = 0.004) and 48 hours (1 ± 2 vs 8 ± 9, P = .1). Also, functional disability was less severe with pH-stat management at 24 hours (P = .002) and 48 hours (P = .053). Neuronal cell damage was less severe with pH-stat versus alpha-stat in the neocortex (4% ± 2% vs 15% ± 7%, P < .001) and hippocampal CA1 region (11% ± 5% vs 33% ± 25%, P = .04), but not in the hippocampal CA3 region (3% ± 5% vs 16% ± 23%, P = .18) or dentate gyrus (1% ± 1% vs 3% ± 6%, P = .63).
Conclusions: pH-stat cardiopulmonary bypass management improves neurologic outcome with deep hypothermic circulatory arrest compared with alpha-stat bypass. The mechanism of protection is not related to hemodynamics, hematocrit, glucose, or brain temperature.
Related Article
J. Thorac. Cardiovasc. Surg. 2001 121: 204-205.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |